Position in ABCL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,065,231
-$58,981 QoQ
Shares Held
305,224
-7.1% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $400,660,289 across 59 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
131,996 | $122,461,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
93,287 | $46,338,451 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
90,348 | $25,746,469 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,910 | $23,014,861 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
350,397 | $20,049,716 | |
| 6 | EXEL |
Exelixis, Inc.
|
343,029 | $18,664,207 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
69,588 | $16,768,620 | |
| 8 | INCY |
Incyte Corp
|
136,684 | $15,494,498 |
All Filings in ABCL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,065,231 | 305,224 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,124,212 | 328,717 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,280,042 | 652,096 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,748,593 | 509,794 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,857,951 | 833,162 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,720,780 | 928,594 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,851,095 | 1,096,575 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,232,820 | 1,092,169 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,150,654 | 2,020,012 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $19,482,548 | 3,412,005 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,475,431 | 3,146,833 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $21,158,444 | 3,275,301 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $24,453,720 | 3,243,199 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $29,439,927 | 2,906,212 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $32,488,867 | 3,285,022 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $35,640,193 | 3,346,497 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $31,100,910 | 3,189,837 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,157,667 | 290,746 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,825,800 | 141,008 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||